{"id":"https://openalex.org/W2145152803","doi":"https://doi.org/10.1183/09031936.03.00031402","title":"Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease","display_name":"Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2145152803","doi":"https://doi.org/10.1183/09031936.03.00031402","mag":"2145152803","pmid":"https://pubmed.ncbi.nlm.nih.gov/12570112"},"language":"en","primary_location":{"id":"doi:10.1183/09031936.03.00031402","doi":"https://doi.org/10.1183/09031936.03.00031402","is_oa":true,"landing_page_url":"https://doi.org/10.1183/09031936.03.00031402","pdf_url":"https://erj.ersjournals.com/content/erj/21/1/74.full.pdf","source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Respiratory Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://erj.ersjournals.com/content/erj/21/1/74.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062318634","display_name":"W Szafra\u0144ski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Szafranski","raw_affiliation_strings":["Dept Lung Diseases, Voivodeship Specialist Hospital, Radom, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept Lung Diseases, Voivodeship Specialist Hospital, Radom, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062396213","display_name":"Alberto Cukier","orcid":"https://orcid.org/0000-0002-7217-9498","observed_orcids":["https://orcid.org/0000-0002-7217-9498"]},"institutions":[{"id":"https://openalex.org/I164915025","display_name":"Mexican Social Security Institute","ror":"https://ror.org/03xddgg98","country_code":"MX","type":"government","lineage":["https://openalex.org/I164915025"]},{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]},{"id":"https://openalex.org/I4210145268","display_name":"Hospital das Cl\u00ednicas da Faculdade de Medicina da Universidade de S\u00e3o Paulo","ror":"https://ror.org/03se9eg94","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210145268"]}],"countries":["BR","MX"],"is_corresponding":false,"raw_author_name":"A. Cukier","raw_affiliation_strings":["Division of Respiratory Diseases,","Hospi-tal de Enfermedades Cardiovasculares y del To \u00b4rax, Monterrey, Mexico","Hospital das Clinicas, University of Sao Paulo, Sao Paulo, Brazil. }"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Respiratory Diseases,","institution_ids":[]},{"raw_affiliation_string":"Hospi-tal de Enfermedades Cardiovasculares y del To \u00b4rax, Monterrey, Mexico","institution_ids":["https://openalex.org/I164915025"]},{"raw_affiliation_string":"Hospital das Clinicas, University of Sao Paulo, Sao Paulo, Brazil. }","institution_ids":["https://openalex.org/I17974374","https://openalex.org/I4210145268"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112329908","display_name":"Ana Sofia Ram\u00edrez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I164915025","display_name":"Mexican Social Security Institute","ror":"https://ror.org/03xddgg98","country_code":"MX","type":"government","lineage":["https://openalex.org/I164915025"]},{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["MX","SE"],"is_corresponding":false,"raw_author_name":"A. Ramirez","raw_affiliation_strings":["Hospi- tal de Enfermedades Cardiovasculares y del To \u00b4rax , Monterrey , Mexico","Division of Respiratory Diseases,","AstraZeneca R&D Lund, SE-22187 Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospi- tal de Enfermedades Cardiovasculares y del To \u00b4rax , Monterrey , Mexico","institution_ids":["https://openalex.org/I164915025"]},{"raw_affiliation_string":"Division of Respiratory Diseases,","institution_ids":[]},{"raw_affiliation_string":"AstraZeneca R&D Lund, SE-22187 Lund, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012894028","display_name":"Guillermo Menga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Menga","raw_affiliation_strings":["Pneumology Dept, Hospital Maria Ferrer, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pneumology Dept, Hospital Maria Ferrer, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032660814","display_name":"Ra\u00fal H. Sansores","orcid":"https://orcid.org/0000-0002-6824-0700","observed_orcids":["https://orcid.org/0000-0002-6824-0700"]},"institutions":[{"id":"https://openalex.org/I4210102695","display_name":"Instituto Nacional de Enfermedades Respiratorias","ror":"https://ror.org/017fh2655","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210102695"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"R. Sansores","raw_affiliation_strings":["Dept of Research in Tobacco Smoking and COPD, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Research in Tobacco Smoking and COPD, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210102695"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023812670","display_name":"S. Nahabedian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"S. Nahabedian","raw_affiliation_strings":["AstraZeneca R&D Lund , SE-22187 Lund , Sweden","Hospital Evita Lanus, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D Lund , SE-22187 Lund , Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Hospital Evita Lanus, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Peterson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"S. Peterson","raw_affiliation_strings":["Astra- Zeneca R&D , Lund , Sweden","Division of Respiratory Diseases,","AstraZeneca R&D Lund, SE-22187 Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astra- Zeneca R&D , Lund , Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Division of Respiratory Diseases,","institution_ids":[]},{"raw_affiliation_string":"AstraZeneca R&D Lund, SE-22187 Lund, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052758096","display_name":"Henric Olsson","orcid":"https://orcid.org/0000-0002-5101-8871","observed_orcids":["https://orcid.org/0000-0002-5101-8871"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"H. Olsson","raw_affiliation_strings":["Astra- Zeneca R&D , Lund , Sweden","Division of Respiratory Diseases,","AstraZeneca R&D Lund, SE-22187 Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astra- Zeneca R&D , Lund , Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Division of Respiratory Diseases,","institution_ids":[]},{"raw_affiliation_string":"AstraZeneca R&D Lund, SE-22187 Lund, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":59.5836,"has_fulltext":true,"cited_by_count":882,"citation_normalized_percentile":{"value":0.99967181,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"21","issue":"1","first_page":"74","last_page":"81"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/budesonide-formoterol","display_name":"budesonide/formoterol","score":0.9929999709129333},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.9070000052452087},{"id":"https://openalex.org/keywords/inhaled-corticosteroids","display_name":"inhaled corticosteroids","score":0.7670000195503235},{"id":"https://openalex.org/keywords/long-acting-beta-agonists","display_name":"long-acting beta2-agonists","score":0.9760000109672546},{"id":"https://openalex.org/keywords/combination-inhaler","display_name":"combination inhaler","score":0.5509999990463257},{"id":"https://openalex.org/keywords/acute-exacerbation-of-copd","display_name":"COPD exacerbations","score":0.902999997138977},{"id":"https://openalex.org/keywords/fev1","display_name":"FEV1","score":0.9330000281333923},{"id":"https://openalex.org/keywords/peak-expiratory-flow","display_name":"peak expiratory flow","score":0.9980000257492065},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.9179999828338623},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.4359999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9844579100608826},{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.8708494901657104},{"id":"https://openalex.org/C2779871671","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Formoterol","level":4,"score":0.8365090489387512},{"id":"https://openalex.org/C2992779976","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Pulmonary disease","level":2,"score":0.7666058540344238},{"id":"https://openalex.org/C2777450039","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Budesonide/formoterol","level":5,"score":0.742168664932251},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5321993231773376},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34569478034973145},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.26834750175476074}],"mesh":[{"descriptor_ui":"D000068759","descriptor_name":"Formoterol Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069502","descriptor_name":"Budesonide, Formoterol Fumarate Drug Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000280","descriptor_name":"Administration, Inhalation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000318","descriptor_name":"Adrenergic beta-Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000318","descriptor_name":"Adrenergic beta-Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004983","descriptor_name":"Ethanolamines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004983","descriptor_name":"Ethanolamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005541","descriptor_name":"Forced Expiratory Volume","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010366","descriptor_name":"Peak Expiratory Flow Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019819","descriptor_name":"Budesonide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019819","descriptor_name":"Budesonide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1183/09031936.03.00031402","doi":"https://doi.org/10.1183/09031936.03.00031402","is_oa":true,"landing_page_url":"https://doi.org/10.1183/09031936.03.00031402","pdf_url":"https://erj.ersjournals.com/content/erj/21/1/74.full.pdf","source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Respiratory Journal","raw_type":"journal-article"},{"id":"pmid:12570112","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12570112","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The European respiratory journal","raw_type":"Clinical Trial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.509.5512","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.509.5512","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://erj.ersjournals.com/content/21/1/74.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1183/09031936.03.00031402","doi":"https://doi.org/10.1183/09031936.03.00031402","is_oa":true,"landing_page_url":"https://doi.org/10.1183/09031936.03.00031402","pdf_url":"https://erj.ersjournals.com/content/erj/21/1/74.full.pdf","source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Respiratory Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2145152803.pdf","grobid_xml":"https://content.openalex.org/works/W2145152803.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W1795103282","https://openalex.org/W1975707290","https://openalex.org/W1991648511","https://openalex.org/W1995337052","https://openalex.org/W2005302880","https://openalex.org/W2025564699","https://openalex.org/W2035236156","https://openalex.org/W2052977441","https://openalex.org/W2066716816","https://openalex.org/W2071058793","https://openalex.org/W2074251558","https://openalex.org/W2087423687","https://openalex.org/W2105281080","https://openalex.org/W2109921129","https://openalex.org/W2110170053","https://openalex.org/W2126675070","https://openalex.org/W2127951128","https://openalex.org/W2133119676","https://openalex.org/W2142243105","https://openalex.org/W2142566654","https://openalex.org/W2149849734","https://openalex.org/W2153236387","https://openalex.org/W2160431793","https://openalex.org/W2167089458","https://openalex.org/W2169715850","https://openalex.org/W2172071634","https://openalex.org/W2172097057","https://openalex.org/W2268275976","https://openalex.org/W2322866941","https://openalex.org/W2331287401","https://openalex.org/W2601324195","https://openalex.org/W3142424398","https://openalex.org/W4236132672"],"related_works":["https://openalex.org/W1520204119","https://openalex.org/W2075352575","https://openalex.org/W7096434935","https://openalex.org/W2058580481","https://openalex.org/W2057984874","https://openalex.org/W1969070857","https://openalex.org/W2380381747","https://openalex.org/W4239017887","https://openalex.org/W2165087980","https://openalex.org/W2765580367"],"abstract_inverted_index":{"The":[0],"efficacy":[1],"and":[2,14,79,100,121,131,144,156,161,176,184,186],"safety":[3,101],"of":[4,59,91,97,110,178,207],"budesonide/formoterol":[5,61,202],"in":[6,18,35,46,159,203],"a":[7,28,199],"single":[8],"inhaler":[9],"compared":[10],"with":[11,20],"placebo,":[12,154],"budesonide":[13,67,155],"formoterol":[15,72],"were":[16,103,166,193],"evaluated":[17],"patients":[19,53],"moderate-to-severe":[21,208],"chronic":[22,209],"obstructive":[23,210],"pulmonary":[24,211],"disease":[25],"(COPD).":[26],"In":[27],"12-month,":[29],"randomised,":[30],"double-blind,":[31],"placebo-controlled,":[32],"parallel-group":[33],"study":[34],"812":[36],"adults":[37],"(mean":[38],"age":[39],"64":[40],"yrs,":[41],"mean":[42,108],"forced":[43],"expiratory":[44,84],"volume":[45],"one":[47],"second":[48],"(FEV1)":[49],"36%":[50],"predicted":[51],"normal),":[52],"received":[54],"two":[55],"inhalations":[56],"twice":[57],"daily":[58],"either":[60],"(Symbicort)":[62],"160/4.5":[63],"microg":[64,69,74],"(delivered":[65],"dose),":[66,71],"200":[68],"(metered":[70],"4.5":[73],"or":[75],"placebo.":[76,190],"Severe":[77],"exacerbations":[78,112],"FEV1":[80,125],"(primary":[81],"variables),":[82],"peak":[83],"flow":[85],"(PEF),":[86],"COPD":[87],"symptoms,":[88],"health-related":[89],"quality":[90],"life":[92],"(HRQL),":[93],"mild":[94],"exacerbations,":[95],"use":[96,177],"reliever":[98,179],"beta2-agonist":[99],"variables":[102],"recorded.":[104],"Budesonide/formoterol":[105,171],"reduced":[106],"the":[107,204],"number":[109],"severe":[111],"per":[113,115],"patient":[114],"year":[116],"by":[117,127],"24%":[118],"versus":[119,123,129,133,142,153,164,182,189],"placebo":[120,130,143,183],"23%":[122],"formoterol.":[124,157],"increased":[126],"15%":[128],"9%":[132],"budesonide.":[134],"Morning":[135],"PEF":[136,150,163],"improved":[137,152,187],"significantly":[138,181],"on":[139],"day":[140],"1":[141,147],"budesonide;":[145],"after":[146],"week,":[148],"morning":[149,160],"was":[151],"Improvements":[158],"evening":[162],"comparators":[165],"maintained":[167],"over":[168],"12":[169],"months.":[170],"decreased":[172],"all":[173],"symptom":[174],"scores":[175],"beta2-agonists":[180],"budesonide,":[185],"HRQL":[188],"All":[191],"treatments":[192],"well":[194],"tolerated.":[195],"These":[196],"results":[197],"suggest":[198],"role":[200],"for":[201],"long-term":[205],"management":[206],"disease.":[212]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":21},{"year":2018,"cited_by_count":22},{"year":2017,"cited_by_count":31},{"year":2016,"cited_by_count":30},{"year":2015,"cited_by_count":33},{"year":2014,"cited_by_count":39},{"year":2013,"cited_by_count":43},{"year":2012,"cited_by_count":49}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}